Mazor Robotics’ Receives Approval to Market its Renaissance Technology in Taiwan
CAESAREA, Israel – January 31, 2013 – Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today announced the Company received approval to market its Renaissance™ system in Taiwan. Pinnaclemed Co., Ltd. will distribute and market the Renaissance technology in the country on behalf of Mazor.
Mazor is marketing its Renaissance technology with its distribution partners in the Asia Pacific region in several countries, including Japan, China, Korea, India, Singapore, Vietnam, and Australia.
“As part of our strategic global growth strategy, we are pleased to build on the base we have established in Asia,” stated Ori Hadomi, CEO. “We made great inroads into the Asia Pacific region in 2012 and believe it offers strong growth opportunities for Mazor in the coming years. We are excited to partner with local distributors to bring our innovative technology to patients and hospitals in Taiwan.”
Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.
About Mazor
Mazor Robotics (TASE:MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 35,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, please visit www.mazorrobotics.com.
U.S. Contacts: EVC Group
Aimee Gordon/Robert Jones-- Investors
agordon@evcgroup.com/bjones@evcgroup.com"> agordon@evcgroup.com/bjones@evcgroup.com
212/850-6020; 646/201-5447
Chris Gale—Media
Cgale@evcgroup.com"> Cgale@evcgroup.com
646/201-5431
Win a few. Lose a few.
Only the long term counts.
